Profile data is unavailable for this security.
About the company
Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company. The Company is developing next-generation cell and gene therapies for immune-based treatment of cancer. The company is developing four drug candidates, two of which are in the field of oncolytic viruses and two in the field of CAR T-cell treatments. Elicera also has a fully developed platform technology called iTANK (ImmunoTherapies Activated with Nap for efficient Killing) for further immune strengthening in treatment in the said field. Elicera has two projects in each field: ELC-100 is an oncolytic virus, also called AdVince, that is in a clinical phase I/II trial, sponsored by Uppsala University, in the treatment of neuroendocrine tumors and ELC-301 is a CAR T-cell therapy in the treatment of B-cell lymphoma, which has been granted support from the Swedish Cancer Society for the planning and implementation of a clinical phase I/II CAR T-cell study.
- Revenue in SEK (TTM)12.85m
- Net income in SEK-19.50m
- Incorporated2014
- Employees2.00
- LocationElicera Therapeutics ABWorld Trade Center GoteborgMassans gata 10, van 7GOETEBORG 412 51SwedenSWE
- Websitehttps://www.elicera.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asarina Pharma AB (publ) | 0.00 | -12.91m | 18.84m | -- | -- | 12.05 | -- | -- | -0.5704 | -0.5704 | 0.00 | 0.069 | 0.00 | -- | -- | -- | -113.04 | -61.28 | -150.47 | -71.81 | -- | -- | -- | -- | -- | -- | 0.3902 | -- | -- | -- | 2.79 | -- | -- | -- |
Lidds AB | 0.00 | -40.21m | 18.90m | 2.00 | -- | 0.6799 | -- | -- | -0.8316 | -0.8316 | 0.00 | 0.2037 | 0.00 | -- | -- | 0.00 | -184.54 | -46.33 | -274.93 | -51.61 | -- | -1,934.24 | -- | -3,076.68 | -- | -- | 0.00 | -- | -100.00 | -- | -9.08 | -- | -- | -- |
AegirBio AB | 36.00k | -49.38m | 19.64m | 13.00 | -- | -- | -- | 545.49 | -2.18 | -2.18 | 0.0015 | -0.3413 | 0.0005 | -- | 0.0065 | 2,769.23 | -67.93 | -- | -82.25 | -- | 355.56 | -- | -137,155.60 | -- | 0.5183 | -43.54 | 1.40 | -- | -94.61 | -- | 83.55 | -- | -- | -- |
Cyxone AB | 0.00 | -21.66m | 23.86m | 1.00 | -- | 0.6956 | -- | -- | -0.1497 | -0.1497 | 0.00 | 0.1589 | 0.00 | -- | -- | -- | -50.57 | -66.19 | -57.08 | -72.35 | -- | -- | -- | -- | -- | -- | 0.0042 | -- | -- | -- | 45.87 | -- | -12.69 | -- |
Circio Holding ASA | 123.37k | -111.07m | 25.45m | 11.00 | -- | -- | -- | 206.31 | -16.75 | -16.75 | 0.0181 | -12.89 | 0.0019 | -- | 0.0072 | 11,181.82 | -172.29 | -46.58 | -- | -53.40 | -- | -- | -90,029.27 | -6,902.00 | -- | -9.82 | 7.73 | -- | -98.77 | 35.43 | 74.42 | -- | -- | -- |
Gabather AB | 0.00 | -9.44m | 31.26m | -- | -- | 50.03 | -- | -- | -0.652 | -0.652 | 0.00 | 0.0331 | 0.00 | -- | -- | -- | -133.71 | -56.57 | -480.99 | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
Fluicell AB | 1.86m | -29.02m | 33.17m | 12.00 | -- | 1.92 | -- | 17.80 | -0.1936 | -0.1936 | 0.0109 | 0.0527 | 0.0796 | 0.5404 | 1.74 | 109,588.20 | -123.93 | -87.55 | -164.04 | -126.02 | 20.93 | 72.97 | -1,557.49 | -650.23 | 3.02 | -- | 0.00 | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
Elicera Therapeutics AB | 12.85m | -19.50m | 34.11m | 2.00 | -- | 1.08 | -- | 2.65 | -0.9726 | -0.9726 | 0.6416 | 0.901 | 0.3015 | -- | 11.43 | 6,426,955.00 | -45.75 | -40.06 | -62.75 | -49.74 | -- | -- | -151.72 | -415.41 | -- | -- | 0.00 | -- | 777.23 | -- | 15.64 | -- | -- | -- |
Lipigon Pharmaceuticals AB | 16.41m | -12.13m | 36.85m | -- | -- | 1.30 | -- | 2.25 | -0.4662 | -0.4662 | 0.3201 | 0.225 | 0.7388 | -- | 14.81 | -- | -54.60 | -314.67 | -75.05 | -426.49 | -- | -- | -73.91 | -488.14 | -- | -- | 0.00 | -- | -- | 444.44 | 67.83 | -- | -- | -- |
Modus Therapeutics Holding AB | 0.00 | -14.96m | 38.63m | 2.00 | -- | 2.65 | -- | -- | -0.7495 | -0.7495 | 0.00 | 0.4056 | 0.00 | -- | -- | 0.00 | -128.10 | -141.06 | -502.76 | -278.44 | -- | -- | -- | -- | -- | -11.79 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
Oncozenge AB | 0.00 | -14.22m | 40.53m | -- | -- | 2.49 | -- | -- | -1.21 | -1.21 | 0.00 | 1.39 | 0.00 | -- | -- | -- | -58.23 | -- | -61.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 65.91 | -- | -- | -- |
SoftOx Solutions AS | 7.00m | -42.21m | 45.92m | -- | -- | -- | -- | 6.56 | -1.98 | -1.98 | 0.3286 | -0.0127 | 0.081 | -- | 1.60 | -- | -48.81 | -50.83 | -82.20 | -64.58 | -- | -- | -602.91 | -646.67 | 0.1745 | -3.45 | -- | -- | -1.88 | 10.06 | 40.85 | -- | 39.43 | -- |
Veg of Lund AB (publ) | 3.10m | -14.81m | 48.90m | 5.00 | -- | 1.29 | -- | 15.75 | -0.5218 | -0.5218 | 0.0893 | 0.9198 | 0.0987 | 9.87 | 4.05 | 443,428.60 | -47.08 | -129.03 | -83.38 | -209.20 | -449.52 | -781.09 | -477.09 | -923.73 | 0.0949 | -11.52 | 0.2468 | -- | 89.57 | 39.87 | 56.02 | -- | -12.47 | -- |
Double Bond Phrmcutcl Intrntnl AB (publ) | 1.49m | -16.07m | 50.51m | 10.00 | -- | 7.84 | -- | 33.88 | -0.1635 | -0.1635 | 0.0145 | 0.0638 | 0.1306 | -- | 26.83 | 149,078.00 | -140.73 | -80.90 | -200.07 | -106.45 | -389.14 | -1,073.66 | -1,078.00 | -1,360.03 | -- | -2.71 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |